📣 Registrations are still open for the FREE, VIRTUAL, Birmingham Adrenal Tumour Masterclass. 21st of September. All you always wanted to know on #phaeochromocytoma #PPGL. 6 CPD credits. Registration link below ⬇️ Cristina Ronchi Yasir Elhassan Vasilis Chortis Birmingham Adrenal Team

Join the first Adrenal Patient Forum hosted by European Society of Endocrinology (ESE). This free event will take place on Zoom. 🎤 "Adrenal insufficiency: daily living and adrenal crisis prevention" 🗓️ Sat 30 Nov, 10:00 - 13:00 CET 🌎 Translations: French, German & Italian addisonsdisease.org.uk/Event/ese-adre…

NEW RESEARCH Evaluation and follow-up of patients diagnosed with #hypophysitis: a cohort study by Aysa Hacioglu et al EJE Volume 191, Issue 3, September 2024 Full paper 👉 doi.org/10.1093/ejendo… ESE Members via 👉 my.ese-hormones.org

Our sLOVEnia Young Endocrinologists, bringing the love for endocrinology to yet another fantastic congress EndoBridge. A perfect place to unite.

⚡️Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial⚡️ 👉9,650 people with T2D, CVD and/or CKD 👉49% got SGLT2i at some point during trial novonordisk.com/content/nncorp…

Among participants with obesity and pain related to knee osteoarthritis, treatment with weekly semaglutide for 68 weeks resulted in greater reductions in body weight and knee pain than placebo. Full STEP 9 trial results: nej.md/40oSLHB

Calling patients with adrenal insufficiency! Join us in a week for our first ESE Adrenal Patient Forum webinar ‘#AdrenalInsufficiency: daily living and adrenal crisis prevention’,. Saturday 30 November 2024, 10:00-13:00 CET. 👉Register for free today! ow.ly/ajJ250Tmrlk

🔆 Neuroendocrinology Watch 🔆 “Phenotype of Pediatric Cushing Syndrome without Obesity” Padilla C et al., EJE, 2024 • Non-obese patients: older, mostly female, advanced puberty. • Different BP profiles by obesity status. • Weight gain not the only clue—screen for hypercort.

💢The last article of 2024‼️‼️ 📌Treatment of acromegaly-induced diabetes: an updated proposal ▶️▶️Acromegaly-induced DM presents unique features due to the direct effects of GH and IGF1 on glucose metabolism #acromegaly Betina Biagetti Free access 👉link.springer.com/epdf/10.1007/s…

Great article published by Michael T McDermott  on “Pseudo-endocrine disorders” (proposed endocrine conditions that have never been scientifically proven to exist) Journal of the Endocrine Society academic.oup.com/jes/article/9/…

Curious about how successful GLP-1 RAs are in syndromic obesity, such as Prader-Willi syndrome? Explore our latest case series on the long-term efficacy and safety of semaglutide in PWS without concomitant diabetes, even after metabolic surgery. 🔎📢 #PWS #obesity #semaglutide

In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: nej.md/4hRGaTY

Front-loading calories may be the key to better weight loss. In this study, eating most calories at breakfast led to: 📉 2.5x greater weight loss (8.7 vs. 3.6 kg) 💪 Better insulin sensitivity (-57 vs. -33%) 🩸 Lower triglycerides (⬇️ 34%) 🍽 Less hunger, more satiety 1/13 🧵

Plastični kirurg Tine Arnež na Facebooku: Za vse, ki ne razumete (ali nočete razumeti), kakšna je situacija na našem oddelku in v našem zdravstvu nasploh…sem našel primerjavo, ki jo je morda lažje razumeti. Predstavljate si, da bi bilo treba v praktično celi Sloveniji

Vrhunski opis situacije na urgenci. Na eni strani (dipl.) sestre, bolnicarji, admin. osebje in zdravniki, ki se resnicno trudijo nuditi humanost socloveku. In na drugi strani tisina Ministrstvo za zdravje ob pocasnem razkroju UC. 2 leti = izgubili 3,2 zdravnika vecer.com/v-soboto/dnevn…

Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017 Metabolism and Systems Science (MSS) Birmingham Health Partners European Society of Endocrinology (ESE) @PituitarySociety ENEA The Pituitary Foundation

Online—Adrenocortical carcinoma: a practical guide for clinicians thelancet.com/journals/landi… #adrenocortical #carcinoma #adrenal #OpenAccess

Breaking! Phase 3 ESSENCE trial results just out: Semaglutide 2.4 mg showed significant improvements for adults with #MASH-63% achieved resolution of steatohepatitis with no worsening of fibrosis vs. 34% on placebo at 72 weeks. #LiverHealth nejm.org/doi/full/10.10… NEJM

🆕 2025 Pituitary Society guidelines on #pituitary incidentalomas 🔹 Always evaluate for hypersecretion & hypopituitarism 🔹 MRI follow-up based on size & features 🔹 Surgery if visual compromise or growth 🔹 Most are benign & stable 📄 Nature Reviews Endocrinology 2025 👇🏼

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity | New England Journal of Medicine nejm.org/do/10.1056/NEJ… CagriSema: body weight reduction of 20.4% versus 3.0% with placebo, with a between-group difference of 17.3 percentage points 68th weeks